Laura was featured in a special edition of Expansión on 21st March 2018 about the leading entrepreneurs of the next decade. Covering the top 20 candidates from all sectors in Catalunya – including mobile phone applications and renewable tech, as well as healthcare – Peptomyc is described as one of the most promising start-ups in the world for cancer treatment.
LATEST NEWS
- MYC inhibition halts metastatic breast cancer progression by blocking tumor growth, invasion & seeding
- Peptomyc receives 377.537€ from Spanish Mineco and European Union joint fund
- PEPTOMYC SL Announces Treatment of First Patient with its Lead Compound OMO-103 in a Phase I/II Clinical Trial
- Green light by the AEMPS to start clinical trials with OMO-103